フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Oncimmune Holdings PLC 19 March 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYQ94H38 Issuer Name...
AIM 17 March 2025 NOTICE 17/03/2025 7:30am TEMPORARY SUSPENSION OF TRADING ON AIM ONCIMMUNE HOLDINGS PLC At the request of the...
Oncimmune Holdings PLC 17 March 2025 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE...
Oncimmune Holdings PLC 14 March 2025 14 March 2025 Oncimmune Holdings plc ("Oncimmune" or the "Company") Block Listing Return Name of...
Oncimmune Holdings PLC 10 March 2025 Oncimmune Holdings Plc ("Oncimmune" or the "Company") Result of General Meeting The General Meeting of...
Oncimmune Holdings PLC 27 February 2025 Oncimmune Holdings Plc ("Oncimmune" or the "Company") Result of Annual General Meeting The...
Oncimmune Holdings PLC 24 February 2025 Oncimmune Holdings plc ("Oncimmune" or the "Company") Strategic update Oncimmune Holdings...
Oncimmune Holdings PLC 18 February 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYQ94H38 Issuer...
Oncimmune Holdings PLC 12 February 2025 Oncimmune Holdings plc ("Oncimmune" or the "Company") Block Listing Return Name of applicant:...
Oncimmune Holdings PLC 12 February 2025 Oncimmune Holdings plc ("Oncimmune" or the "Company") Posting of Notice of General Meeting ...
Oncimmune Holdings PLC on Monday said its revenue more than doubled in financial 2024, and it expects further growth ...
Oncimmune Holdings PLC 10 February 2025 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE...
Oncimmune Holdings PLC 04 February 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYQ94H38 Issuer...
Oncimmune Holdings PLC 03 February 2025 Oncimmune Holdings plc ("Oncimmune" or the "Company") Notice of Annual General Meeting ...
s PLC - Leeds, England-based autoantibody profiling research services to pharmaceutical and biotechnology industry to ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す